Pharma tariff row: Common ailment, uncommon prescription Fortune IndiaUS generics tariffs more negotiation tactic than real threat: Biocon’s Kiran Mazumdar-Shaw livemint.comPower, politics and pharma Express PharmaSandoz in Talks With U.S. Government About Potential Investment, CEO Says WSJPharmaceutical Tariffs Return to the Headlines cliffordchance.com
